OBJECTIVES: The objective of this randomized, controlled study was to determine the usefulness of a decision aid on pre-donation of autologous blood before elective open heart surgery. METHODS: The decision aid (DA) group received a tape and booklet which described the options for peri-operative transfusion in detail. The no decision aid (NDA) group received information usually given to patients about autologous donation. RESULTS: A total of 120 patients were randomized. The DA group rated themselves better prepared for decision making and showed significant improvements in knowledge (p = 0.001) and realistic risk perceptions (p = 0.001). In both groups there was an increase in the proportion of patients choosing allogeneic blood between baseline and follow-up (p = 0.001). Patients in the DA group were significantly more satisfied with the amount of information they received, how they were treated and with the decision they made, than patients in the NDA group. CONCLUSION: The decision aid is useful in preparing patients for decision making. PRACTICE IMPLICATIONS: The next stage is to explore strategies to make it available to all appropriate patients.
RCT Entities:
OBJECTIVES: The objective of this randomized, controlled study was to determine the usefulness of a decision aid on pre-donation of autologous blood before elective open heart surgery. METHODS: The decision aid (DA) group received a tape and booklet which described the options for peri-operative transfusion in detail. The no decision aid (NDA) group received information usually given to patients about autologous donation. RESULTS: A total of 120 patients were randomized. The DA group rated themselves better prepared for decision making and showed significant improvements in knowledge (p = 0.001) and realistic risk perceptions (p = 0.001). In both groups there was an increase in the proportion of patients choosing allogeneic blood between baseline and follow-up (p = 0.001). Patients in the DA group were significantly more satisfied with the amount of information they received, how they were treated and with the decision they made, than patients in the NDA group. CONCLUSION: The decision aid is useful in preparing patients for decision making. PRACTICE IMPLICATIONS: The next stage is to explore strategies to make it available to all appropriate patients.
Authors: Michael J Hall; Sharon L Manne; Gary Winkel; Daniel S Chung; David S Weinberg; Neal J Meropol Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-06 Impact factor: 4.254
Authors: Kathryn E Flynn; Kevin P Weinfurt; Damon M Seils; Li Lin; Caroline B Burnett; Kevin A Schulman; Neal J Meropol Journal: J Empir Res Hum Res Ethics Date: 2008-09 Impact factor: 1.742
Authors: Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas Journal: Can Respir J Date: 2006-03 Impact factor: 2.409
Authors: Salma Shickh; Marc Clausen; Chloe Mighton; Selina Casalino; Esha Joshi; Emily Glogowski; Kasmintan A Schrader; Adena Scheer; Christine Elser; Seema Panchal; Andrea Eisen; Tracy Graham; Melyssa Aronson; Kara M Semotiuk; Laura Winter-Paquette; Michael Evans; Jordan Lerner-Ellis; June C Carroll; Jada G Hamilton; Kenneth Offit; Mark Robson; Kevin E Thorpe; Andreas Laupacis; Yvonne Bombard Journal: BMJ Open Date: 2018-04-26 Impact factor: 2.692
Authors: Sandra L Carroll; Dawn Stacey; Michael McGillion; Jeff S Healey; Gary Foster; Sarah Hutchings; Heather M Arthur; Gina Browne; Lehana Thabane Journal: Pilot Feasibility Stud Date: 2017-11-21